Riverway Discoveries

Riverway Discoveries is a preclinical-stage biotechnology company focused on the discovery and development of novel small molecule therapeutics for high-impact unmet medical needs. Spun out from the University of Minnesota's Institute for Therapeutics Discovery & Development (ITDD), the company leverages the extensive medicinal chemistry and drug discovery expertise of its founders. Its primary research programs target non-hormonal male contraception and specific oncology indications, utilizing a platform designed to optimize lead compounds for challenging biological targets. By bridging the gap between academic innovation and commercial drug development, Riverway Discoveries aims to advance first-in-class candidates through early-stage development. The company maintains a strong collaborative relationship with the University of Minnesota to access cutting-edge research and infrastructure.